Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
103.10
+3.00 (3.00%)
At close: Apr 28, 2026, 4:00 PM EDT
103.10
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:55 PM EDT
Veradermics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -70 | -26.49 | -16.49 |
| Loss (Gain) From Sale of Investments | -0.56 | - | - |
| Stock-Based Compensation | 1.44 | 0.25 | 0.21 |
| Other Operating Activities | 1.4 | 1.82 | 1.85 |
| Change in Accounts Payable | -0.12 | 0.65 | 1.35 |
| Change in Other Net Operating Assets | -3.76 | 0.09 | -0.43 |
| Operating Cash Flow | -71.6 | -23.69 | -13.51 |
| Capital Expenditures | -0.02 | - | - |
| Investment in Securities | -118.83 | - | - |
| Investing Cash Flow | -118.86 | - | - |
| Long-Term Debt Issued | - | 8.51 | - |
| Long-Term Debt Repaid | - | -0.85 | - |
| Net Debt Issued (Repaid) | - | 7.66 | - |
| Issuance of Common Stock | 0.16 | - | - |
| Other Financing Activities | -0.45 | -0.28 | -0.04 |
| Financing Cash Flow | 159.14 | 60.48 | 13.9 |
| Net Cash Flow | -31.32 | 36.79 | 0.39 |
| Free Cash Flow | -71.63 | -23.69 | -13.51 |
| Free Cash Flow Per Share | -96.14 | -32.14 | -18.33 |
| Cash Interest Paid | - | 0.1 | - |
| Levered Free Cash Flow | -47.55 | -16.37 | - |
| Unlevered Free Cash Flow | -47.55 | -16.01 | - |
| Change in Working Capital | -3.89 | 0.73 | 0.92 |
Source: S&P Capital IQ. Standard template.
Financial Sources.